- Home
- RCUS vs CCU Comparison
RCUS vs CCU Comparison
Compare RCUS & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | CCU |
|---|---|---|
| Founded | 2015 | 1850 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2018 | 1992 |
Fundamental Metrics
Financial Performance| Metric | RCUS | CCU |
|---|---|---|
| Price | $20.03 | $14.15 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 9 | 2 |
| Target Price | ★ $28.89 | $12.00 |
| AVG Volume (30 Days) | ★ 1.2M | 194.1K |
| Earning Date | 02-24-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | N/A | ★ 5.98 |
| EPS | N/A | ★ 0.38 |
| Revenue | $240,000,000.00 | ★ $3,145,028,795.00 |
| Revenue This Year | N/A | $3.14 |
| Revenue Next Year | N/A | $4.97 |
| P/E Ratio | ★ N/A | $18.63 |
| Revenue Growth | N/A | ★ 20.53 |
| 52 Week Low | $6.50 | $11.35 |
| 52 Week High | $26.40 | $15.75 |
Technical Indicators
Market Signals| Indicator | RCUS | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 49.42 |
| Support Level | $20.79 | $14.30 |
| Resistance Level | $22.29 | $15.00 |
| Average True Range (ATR) | 1.13 | 0.40 |
| MACD | -0.20 | -0.11 |
| Stochastic Oscillator | 0.45 | 21.57 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.